Biohaven Pharmaceutical Holding Company Stock

Biohaven Pharmaceutical Holding Company Dividend 2024

Biohaven Pharmaceutical Holding Company Dividend

0 USD

Biohaven Pharmaceutical Holding Company Dividend yield

Ticker

BHVN

ISIN

VGG111961055

WKN

A2DQ7W

How much dividend does Biohaven Pharmaceutical Holding Company 2024 pay?

According to the latest status from October 2024, Biohaven Pharmaceutical Holding Company paid a total of 0 USD per share in dividends within the last 12 months. With the current Biohaven Pharmaceutical Holding Company price of 49.97 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Biohaven Pharmaceutical Holding Company Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Biohaven Pharmaceutical Holding Company Dividend Safe?

Biohaven Pharmaceutical Holding Company has been increasing the dividend for 0 years.

Over the past 10 years, Biohaven Pharmaceutical Holding Company has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Biohaven Pharmaceutical Holding Company's Dividend Distributions

Biohaven Pharmaceutical Holding Company’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Biohaven Pharmaceutical Holding Company's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Biohaven Pharmaceutical Holding Company's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Biohaven Pharmaceutical Holding Company’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Biohaven Pharmaceutical Holding Company Aktienanalyse

What does Biohaven Pharmaceutical Holding Company do?

Biohaven Pharmaceutical is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. It was founded in 2013 and is headquartered in New Haven, Connecticut. The company's business model is based on discovering and developing novel medications for conditions such as migraine, spinal muscular atrophy, Alzheimer's, and other neurological disorders. Biohaven invests in research and development to create therapies that can enhance patients' lives. It has divisions dedicated to developing treatments for migraine, neurodegeneration, and spinal muscular atrophy. Biohaven's first product, Rimegepant, is a migraine medication that inhibits the CGRP receptor. It has been approved in the US for migraine treatment. Troriluzol, another migraine medication, is still in clinical development. Biohaven is also active in the fields of Alzheimer's and ALS, with medications like BHV-0223 and BHV-4157 in development. The company aims to develop innovative medications that can improve and restore patient health. It collaborates with other companies and research institutions to maximize its research potential and bring innovative therapies to market faster. Overall, Biohaven Pharmaceutical is a leading biopharmaceutical company dedicated to developing innovative therapies for neurological disorders, with a strong pipeline of medications and a committed research and development department working towards improving global patient healthcare. Biohaven Pharmaceutical Holding Company is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Biohaven Pharmaceutical Holding Company stock

How much dividend does Biohaven Pharmaceutical Holding Company pay?

Over the past 12 months, Biohaven Pharmaceutical Holding Company paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biohaven Pharmaceutical Holding Company is expected to pay a dividend of 0 USD.

What is the dividend yield of Biohaven Pharmaceutical Holding Company?

The current dividend yield of Biohaven Pharmaceutical Holding Company is .

When does Biohaven Pharmaceutical Holding Company pay dividends?

Biohaven Pharmaceutical Holding Company pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biohaven Pharmaceutical Holding Company?

Biohaven Pharmaceutical Holding Company paid dividends every year for the past 0 years.

What is the dividend of Biohaven Pharmaceutical Holding Company?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biohaven Pharmaceutical Holding Company located?

Biohaven Pharmaceutical Holding Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biohaven Pharmaceutical Holding Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biohaven Pharmaceutical Holding Company from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Biohaven Pharmaceutical Holding Company pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Biohaven Pharmaceutical Holding Company in the year 2023?

In the year 2023, Biohaven Pharmaceutical Holding Company distributed 0 USD as dividends.

In which currency does Biohaven Pharmaceutical Holding Company pay out the dividend?

The dividends of Biohaven Pharmaceutical Holding Company are distributed in USD.

Andere Kennzahlen von Biohaven Pharmaceutical Holding Company

Our stock analysis for Biohaven Pharmaceutical Holding Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biohaven Pharmaceutical Holding Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.